PayPay Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
PayPay Securities's BMY Position: Q2 2026 in Review
PayPay Securities increased its Bristol-Myers Squibb (BMY) stake by 445% in Q2 2026, buying an estimated $9.7K and bringing the position to 207 shares worth $11.9K. The position accounts for 0.29% of the portfolio, ranked #53.
PayPay Securities first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- PayPay Securities held 207 shares of Bristol-Myers Squibb worth $11.9K as of Q2 2026.
- PayPay Securities bought 169 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.7K.
- Bristol-Myers Squibb made up 0.29% of PayPay Securities's portfolio in Q2 2026, its #53 holding.
- PayPay Securities first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.